Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;125(2):397-403.e10.
doi: 10.1016/j.jaci.2009.10.072.

Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps

Anju T Peters  1 , Atsushi Kato, Ning Zhang, David B Conley, Lydia Suh, Brian Tancowny, Derek Carter, Tara Carr, Michael Radtke, Kathryn E Hulse, Sudarshan Seshadri, Rakesh Chandra, Leslie C Grammer, Kathleen E Harris, Robert Kern, Robert P Schleimer
Affiliations

Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps

Anju T Peters et al. J Allergy Clin Immunol. 2010 Feb.

Abstract

Background: IL-6 activates T(H)17 cells and regulates the response of B lymphocytes and regulatory T cells. The IL-6 receptor and the membrane protein, glycoprotein 130 (gp130), form an active signaling complex that signals through signal transducer and activator of transcription 3 (STAT3) and other signaling molecules. Both the IL-6 receptor (IL-6R) and gp130 can be found in soluble forms that regulate the pathway.

Objective: We measured IL-6 signaling components and IL-17 in chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP), CRS without nasal polyps (CRSsNP), and controls to assess the IL-6 pathway in CRS.

Methods: IL-6, soluble IL-6R, soluble gp130 (sgp130), and IL-17 were measured in sinus tissue extracts and in nasal lavage fluid by either cytokine bead array or ELISA. phosphoSTAT3 (p-STAT3) was determined by Western blot and by immunohistochemistry.

Results: IL-6 protein was significantly (P < .001) increased in CRSwNP compared with CRSsNP and controls. Soluble IL-6R was also increased in nasal polyp compared with control tissue (P < .01). Despite elevated IL-6 and sIL-6R, IL-17A, E, and F were undetectable in the sinus tissue from most of the patients with CRS and controls. p-STAT3 levels were reduced in the polyp tissue, possibly indicating reduced activity of IL-6 in the tissue. sgp130 was elevated in CRSwNP compared with CRSsNP and controls.

Conclusion: p-STAT3 levels are decreased in CRSwNP despite increased levels of IL-6 and sIL-6R and are associated with the absence of an IL-17 response. This may be a response to elevated levels of sgp130, a known inhibitor of IL-6 signaling. These results indicate that IL-6 and its signaling pathway may be altered in CRSwNP.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Assessment of IL-6 and soluble IL-6 receptor (sIL-6R) levels in CRS by ELISA. A, IL-6 levels were increased in nasal polyps compared to sinus tissues from controls and CRSsNP. B, sIL-6R levels were increased in the polyp tissue compared to sinus tissue from controls. Levels were marginally increased (p=0.06) in CRSwNP compared to CRSsNP.
Figure 2
Figure 2
A, Representative western blot of p-STAT3 and total STAT3 in nasal polyps and controls. B, Densitometric analysis of p-STAT3 from four controls and six CRSwNP subjects shown in A. C, Densitometric analysis of p-STAT3 from seven controls and nine CRSwNP subjects. D, Representative western blot of p-STAT3 in nasal polyp (n=3) and inferior turbinate tissue (n=3) within the same CRSwNP patients. E, (1) Isotype control antibody staining in control tissue. (2) Representative immunostaining for p-STAT3 in control tissue.
Figure 3
Figure 3
Soluble glycoprotein 130 (sgp130) levels are increased in polyp tissue compared to sinus tissue from controls by ELISA.
See this image and copyright information in PMC

Comment in

  • Plasticity of airway epithelial cells.
    Avila PC. Avila PC. J Allergy Clin Immunol. 2011 Dec;128(6):1225-6. doi: 10.1016/j.jaci.2011.10.006. J Allergy Clin Immunol. 2011. PMID: 22133319 Free PMC article. No abstract available.

References

    1. Meltzer E, Hamilos DA, Hadley JA, Lanza DC, Marple BF, Nicklas RA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004;114:S155–S212. - PMC - PubMed
    1. Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61:1280–1289. - PubMed
    1. Bachert C, Gevert P, van Cauwenberge P. Staphylococcus aureus superantigens and airway disease. Curr Allergy Asthma Rep. 2002;2:252–258. - PubMed
    1. Shin SH, Ponikau JU, Sherris DA, Congdon D, Frigas E, Homburger HA, et al. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol. 2004;114:1369–1375. - PubMed
    1. Kramer MF, Ostertag P, Pfrogner E, Rasp G. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis. Laryngoscope. 2000;110:1056–1062. - PubMed

Publication types

MeSH terms